Benutzer: Gast  Login
Titel:

[ASCO- and ESMO-update 2017 - highlights of the 53. meeting of the American Society of Clinical Oncology/ASCO 2017 and European Society for Medical Oncology/ESMO congress 2017].

Dokumenttyp:
Congress; Article
Autor(en):
Ettrich, Thomas J; Ebert, Matthias; Lorenzen, Sylvie; Moehler, Markus; Vogel, Arndt; Witkowski, Lukas; Seufferlein, Thomas; Reinacher-Schick, Anke
Abstract:
At ASCO 2017, and subsequently the ESMO congress 2017, a number of studies were presented which, in part, may change the present standard of therapy in gastrointestinal oncology. The German FLOT4 trial established perioperative Docetaxel, Oxaliplatin and 5-Fluorouracil (5-FU) as the new treatment standard for resectable adenocarcinoma of the gastroesophageal junction and the stomach. In hepatocellular carcinoma (HCC), two large studies did not show a survival benefit for selective internal thera...     »
Zeitschriftentitel:
Z Gastroenterol
Jahr:
2018
Band / Volume:
56
Heft / Issue:
4
Seitenangaben Beitrag:
384-397
Volltext / DOI:
doi:10.1055/s-0044-101757
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/29642252
Print-ISSN:
0044-2771
TUM Einrichtung:
III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
 BibTeX